Cafepharma Today

January 28 2025 - Versant invests again in obesity, this time backing Helicore Biopharma
Versant invests again in obesity, this time backing Helicore Biopharma
Enhertu, with new FDA OK, set to supplant chemo in HER2-low breast cancer
Takeda regains home rights to phase 3-stage depression drug from Neurocrine
Stopwatch starts on reviews of GSK's long-acting asthma drug
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Cost-Cutting Done, Pharma Heads Weigh New Challenges
NJBiz.com
Monday, December 1, 2008 - 10:10am
tags:
Some US doctors may give up vaccines due to cost
Google/AP
Monday, December 1, 2008 - 10:07am
tags:
Paladin Labs signs agreement with GSK for ADHD drug
Trading Markets
Monday, December 1, 2008 - 9:56am
tags:
Overseas Clinical Trials Are Under the Microscope
WSJ Online
Monday, December 1, 2008 - 9:42am
tags:
Wyeth Employee Balks At Outsourcing & Gets Fired
Pharmalot
Monday, December 1, 2008 - 9:15am
tags:
J&J to buy breast implant firm Mentor for $1.1 billion
Reuters
Monday, December 1, 2008 - 9:14am
tags:
Pig virus concern for Solvay enzyme -FDA
Reuters AlertNet
Monday, December 1, 2008 - 8:16am
tags:
Lower-cost drugs predicted under Obama administration
Chicago Tribune, IL
Monday, December 1, 2008 - 8:15am
tags:
Roche Financing For Genentech Deal Looks Tough
Pharmalot
Monday, December 1, 2008 - 8:14am
tags:
Cell Therapeutics receives FDA priority review for expanded use of cancer drug Zevalin
Yahoo/AP
Monday, December 1, 2008 - 8:02am
tags:
Vical receives $1 million payment for licensing deal on potential cancer drug with Merck
Yahoo/AP
Monday, December 1, 2008 - 8:02am
tags:
Latest Postmortem on Torcetrapib Leaves Hope for HDL Boosters
WSJ Online
Monday, December 1, 2008 - 7:35am
tags:
Lilly Drops Its Cymbalta Application
WSJ Online
Monday, December 1, 2008 - 7:34am
tags:
Teva Grabs Billions Gambling on Copies of Brand-Name Drugs
Bloomberg
Monday, December 1, 2008 - 7:33am
tags:
China Biotech in Review: Deals and Healthcare Stimulus
Seeking Alpha
Sunday, November 30, 2008 - 11:30am
tags:
Teva looks set to win German tender
Globes, Israel
Sunday, November 30, 2008 - 11:29am
tags:
Europe Accuses Drug Makers of Padding Health Care Costs
Ocala.com, FL
Sunday, November 30, 2008 - 11:26am
tags:
Cook's growth is still sizzling
Indianapolis Star, IN
Sunday, November 30, 2008 - 10:37am
tags:
Cell Therapeutics, Spectrum in deal to sell Zevalin
bizjournals
Sunday, November 30, 2008 - 10:27am
tags:
BioCryst named 29th fastest growing tech firm
bizjournals
Sunday, November 30, 2008 - 10:25am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information